The treatment of Cataracts & Restless Legs Syndrome with vitamins

Cataracts and Restless Legs Syndrome: Mitamins custom make quality formulas for the treatment of Cataracts & Restless Legs Syndrome with vitamins. A Cataracts & Restless Legs Syndrome formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Cataracts and Restless Legs Syndrome

  • Amount Per Serving
    % DV
    Vitamin C
    100
    mg
    167%
    Vitamin D
    100
    IU
    25%
    Vitamin E
    100
    IU
    333%
    Riboflavin
    75
    mg
    4412%
    Folate
    400
    mcg
    100%
    Calcium
    100
    mg
    10%
    Magnesium
    50
    mg
    13%
  • Amount Per Serving
    % DV
    Selenium
    200
    mcg
    286%
    Alpha Lipoic Acid
    50
    mg
    *
    Lutein
    6000
    mcg
    *
    Bilberry Extract
    50
    mg
    *
    Ginkgo Extract
    40
    mg
    *
    Grape Seed Extract
    25
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Cataracts and Restless Legs Syndrome
Serving Size:4-5

Cataracts and Restless Legs Syndrome Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
FDA Proposes New Rules for Sunscreens (HealthDay)
The U.S. Food and Drug Administration (FDA) proposed Thursday a new rating system for sunscreens that would, for the first time, alert consumers as to how well they block dangerous ultraviolet A (UVA) rays.
Actavis Receives Approval For Ranitidine Syrup In The U.S.
Actavis U.S., the United States manufacturing and marketing division of the international generic pharmaceuticals company Actavis Group (ICEX: ACT), today announced that it has received approval from the U.S. Food & Drug Administration (FDA) to market Ranitidine Oral Solution USP. Due to Actavis's first-to-file status, the FDA has granted Actavis a 180-day marketing exclusivity that will commence with the distribution of the product in the coming weeks.
This information concerning the support of Cataracts and Restless Legs Syndrome treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments